Literature DB >> 16156510

Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.

Kazuyoshi Kirimura1, Shinji Takai, Denan Jin, Michiko Muramatsu, Kanta Kishi, Katsuhiro Yoshikawa, Mika Nakabayashi, Yoshiki Mino, Mizuo Miyazaki.   

Abstract

Vascular smooth muscle cells in spontaneously hypertensive rats (SHR) express angiotensin II-forming chymase (rat vascular chymase [RVCH]), which may contribute to blood pressure regulation. In this study, we studied whether chymase-dependent angiotensin II formation contributes to the regulation of blood pressure in SHR. The systolic blood pressure in 16-week-old Wistar-Kyoto (WKY) rats was 113 +/- 9 mmHg, compared to 172 +/- 3 mmHg in SHR. Using synthetic substrates for measuring angiotensin-converting enzyme (ACE) and chymase activities, it was found that both ACE and chymase activities in extracts from SHR aortas were significantly higher than in those from WKY rat aortas. Using angiotensin I as a substrate, angiotensin II formation in SHR was found to be significantly higher than that in WKY rats, and its formation was completely suppressed by an ACE inhibitor, but not by a chymase inhibitor. RVCH mRNA expression could not be detected in aorta extracts from either WKY rats or SHR. In carotid arteries isolated from WKY rats and SHR, angiotensin I-induced vasoconstriction was completely suppressed by an ACE inhibitor, but not by a chymase inhibitor. Angiotensin I-induced pressor responses in both WKY rats and SHR were also completely inhibited by an ACE inhibitor, but they were not affected by a chymase inhibitor. In SHR, an ACE inhibitor and an angiotensin II receptor blocker showed equipotent hypotensive effects, but a chymase inhibitor did not have a hypotensive effect. These results indicated that chymase-dependent angiotensin II did not regulate blood pressure in SHR in the present study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16156510     DOI: 10.1291/hypres.28.457

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  10 in total

1.  Pancreatic source of protease activity in the spontaneously hypertensive rat and its reduction during temporary food restriction.

Authors:  Amy Hsueh Wen Chan; Geert W Schmid-Schönbein
Journal:  Microcirculation       Date:  2019-05-03       Impact factor: 2.628

2.  Mast Cell Inhibition Attenuates Cardiac Remodeling and Diastolic Dysfunction in Middle-aged, Ovariectomized Fischer 344 × Brown Norway Rats.

Authors:  Hao Wang; Jaqueline da Silva; Allan Alencar; Gisele Zapata-Sudo; Marina R Lin; Xuming Sun; Sarfaraz Ahmad; Carlos M Ferrario; Leanne Groban
Journal:  J Cardiovasc Pharmacol       Date:  2016-07       Impact factor: 3.105

Review 3.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

Review 4.  Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018).

Authors:  Sarfaraz Ahmad; Carlos M Ferrario
Journal:  Expert Opin Ther Pat       Date:  2018-10-10       Impact factor: 6.674

5.  Big ET-1 processing into vasoactive peptides in arteries and veins.

Authors:  Stephanie W Watts; Keshari Thakali; Chuck Smark; Catherine Rondelli; Gregory D Fink
Journal:  Vascul Pharmacol       Date:  2007-09-07       Impact factor: 5.773

6.  Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes.

Authors:  Sarfaraz Ahmad; Jasmina Varagic; Brian M Westwood; Mark C Chappell; Carlos M Ferrario
Journal:  PLoS One       Date:  2011-01-10       Impact factor: 3.240

Review 7.  Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis.

Authors:  Shinji Takai; Denan Jin
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

8.  Chymase Dependent Pathway of Angiotensin II Generation and Rapeseed Derived Peptides for Antihypertensive Treatment of Spontaneously Hypertensive Rats.

Authors:  Iwona Baranowska; Olga Gawrys; Malwina M Roszkowska-Chojecka; Bozena Badzynska; Dagmara Tymecka; Krzysztof H Olszynski; Elzbieta Kompanowska-Jezierska
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

9.  Extended Cleavage Specificity of the Rat Vascular Chymase, a Potential Blood Pressure Regulating Enzyme Expressed by Rat Vascular Smooth Muscle Cells.

Authors:  Petter Berglund; Srinivas Akula; Zhirong Fu; Michael Thorpe; Lars Hellman
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

Review 10.  Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?

Authors:  Mark Sweeney; Ben Corden; Stuart A Cook
Journal:  EMBO Mol Med       Date:  2020-09-21       Impact factor: 12.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.